Mike Druckman

ID: 1b837770-2619-30fb-68c4

/

Unclaimed

/

Organization: Hogan Lovells

FDA Issues Interim cGMP Guidance for Outsourcing Facilities

Focus on Regulation · July 24, 2014

FDA Issues New Draft Guidance on Identification of Suspect Products and Notification

Focus on Regulation · June 16, 2014

Webinar | FDA’s Regulation of Stem Cells and Regenerative Medicine in Light of Regenerative Sciences

Focus on Regulation · March 21, 2014

D.C. Circuit Issues Landmark Ruling for Stem Cell Therapies

Focus on Regulation · February 5, 2014

FDA Calls for Nominations of Difficult to Compound Drugs

Focus on Regulation · December 16, 2013